Antidepressant-like effect of Albizia zygia root extract in murine models

References

[1] World Health Organisation. Depression: a global public health concern. Available at: http://www.who.int/mental_health/management/depression/who_paper_depression_wfmh_2012.pdf. Accessed: 14 Dec 2019.Suche in Google Scholar

[2] World Health Organisation. Mental health action plan 2013–2020. Geneva: WHO, 2013.Suche in Google Scholar

[3] Keks N, Hope J, Keogh S. Switching and stopping antidepressants. Aust Prescr 2016;39:76–83.10.18773/austprescr.2016.039Suche in Google Scholar

[4] Kirsch I. Antidepressants and the placebo effect. Z Psychol 2015;222:122–34.10.1027/2151-2604/a000176Suche in Google Scholar PubMed PubMed Central

[5] Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008;5:e45.10.1371/journal.pmed.0050045Suche in Google Scholar PubMed PubMed Central

[6] Thaipisuttikul P, Pichai I, Waleeprakhon P, Wisajun P, Jullagate S. Psychiatric comorbidities in patients with major depressive disorder. Neuropsychiatr Dis Treat 2014;10:2097.10.2147/NDT.S72026Suche in Google Scholar PubMed PubMed Central

[7] Apetorgbor M. Albizia zygia (DC.) JF Macbr. In: Louppe D, Oteng-Amoako AA, Brink M, editors, PROTA (Plant resources of tropical Africa/Resources végétales de l’Afrique tropicale). Leiden: Backhuys Publishers, 2008:67–71.Suche in Google Scholar

[8] Arbonnier M. Trees, shrubs and lianas of West African dry zones. Weikersheim: Margraf Publishers, 2004:382–5.Suche in Google Scholar

[9] Bouquet A, Debray M. Plantes medicinales de la Cote d’Ivoire. Travaux et documents de l’ORSTOM No 32. Paris: ORSTOM, 1974:119.Suche in Google Scholar

[10] Abotsi WK, Lamptey SB, Boakye-Gyasi E, Woode E. Albizia zygia (DC.) J.F. Macbr. (Leguminosae-Mimosoideae) root extract exhibits anti-nociceptive and antipyretic activities in murine models. J Ethnopharmacol 2017;199:183–93.10.1016/j.jep.2017.02.007Suche in Google Scholar PubMed

[11] Lamptey SB, Abotsi WK. Albizia zygia (DC.) Macbr. hydroethanol root extract exerts anti-oedemic and in vivo antioxidant activities in animal models. J Appl Pharm Sci 2017;7:199–205.10.1016/j.jep.2017.02.007Suche in Google Scholar

[12] Kumbol VW-A, Abotsi WK, Ekuadzi E, Woode E. Albizia zygia root extract exhibits antipsychotic-like properties in murine models of schizophrenia. Biomed Pharmacother 2018;106:831–41.10.1016/j.biopha.2018.07.030Suche in Google Scholar PubMed

[13] Abere TA, Ibanishuka P, Jesuorobo RI. Analgesic and toxicological evaluation of the stem bark of Albizia zygia Benth (Mimosoideae). IOSR J Pharm Biol Sci 2014;9:26–31.10.9790/3008-09242631Suche in Google Scholar

[14] Abdalla MA, Laatsch H. Flavonoids from Sudanese Albizia zygia (Leguminosae, subfamily Mimosoideae), a plant with antimalarial potency. Afr J Tradit Complement Altern Med. 2012;9:56–8.10.4314/ajtcam.v9i1.8Suche in Google Scholar PubMed PubMed Central

[15] Noté OP, Simo L, Mbing JN, Guillaume D, Aouazou SA, Muller CD, et al. Two new triterpenoid saponins from the roots of Albizia zygia (DC.) JF Macbr. Phytochem Lett 2016;18:128–35.10.1016/j.phytol.2016.09.010Suche in Google Scholar

[16] Noté OP, Simo LM, Mbing JN, Guillaume D, Muller CD, Pegnyemb DE, et al. Structural determination of two new acacic acid-type saponins from the stem barks of Albizia zygia (DC.) J. F. Macbr. Nat Prod Res 2019;33:180–8.10.1080/14786419.2018.1440228Suche in Google Scholar PubMed

[17] Pachaly P, Redeker F, Schoppa T. Inhaltsstoffe von Albizzia zygia, 2. Mitt. Constituents of Albizzia zygia, II. Arch Pharm (Weinheim) 1983;316:651–2.10.1002/ardp.19833160715Suche in Google Scholar

[18] Schoppa T, Pachaly P. Inhaltsstoffe von Albizzia zygia. Arch Pharm (Weinheim) 1981;314:18–25.10.1002/ardp.19813140105Suche in Google Scholar

[19] Bapna J, Dandiya P. Modification of the effects of antipsychotic agents on the “open field” performance of rats by treatment with α-methyl tyrosine or p-chlorophenylalanine. Psychopharmacology 1970;17:361–66.10.1007/BF00403807Suche in Google Scholar PubMed

[20] Adongo DW, Mante PK, Woode E, Ameyaw EO, Kukuia KK. Effects of hyrdroethanolic leaf extract of Pseudospondias microcarpa (A. Rich.) Engl.(Anacardiaceae) on the central nervous system in mice. J Phytopharmacol 2014;3:410–7.10.31254/phyto.2014.3607Suche in Google Scholar

[21] Biney RP, Benneh CK, Ameyaw EO, Boakye-Gyasi E, Woode E. Xylopia aethiopica fruit extract exhibits antidepressant-like effect via interaction with serotonergic neurotransmission in mice. J Ethnopharmacol 2016;184:49–57.10.1016/j.jep.2016.02.023Suche in Google Scholar PubMed

[22] Kukuia KK, Ameyaw EO, Woode E, Mante PK, Adongo DW. Scientific evidence of plant with a rapid-onset and sustained antidepressant effect in a chronic model of depression: mallotus oppositifolius. J Basic Clin Physiol Pharmacol 2016;27:523–32.10.1515/jbcpp-2015-0029Suche in Google Scholar PubMed

[23] Liu J, Zhai W-M, Yang Y-X, Shi J-L, Liu Q-T, Liu G-L, et al. GABA and 5-HT systems are implicated in the anxiolytic-like effect of spinosin in mice. Pharmacol Biochem Behav 2015;128:41–9.10.1016/j.pbb.2014.11.003Suche in Google Scholar PubMed

[24] Mante PK, Woode E, Kukuia KK, Adongo DW, Ameyaw EO. Antidepressant-like properties of Antiaris toxicaria aqueous extract. Int J Bas Clin Pharmacol 2015;4:111–20.10.5455/2319-2003.ijbcp20150220Suche in Google Scholar

[25] O’Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology 2007;192:357–71.10.1007/s00213-007-0728-9Suche in Google Scholar PubMed

[26] Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985;85:367–70.10.1007/BF00428203Suche in Google Scholar PubMed

[27] Porsolt R, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977;266:730.10.1038/266730a0Suche in Google Scholar PubMed

[28] Stone EA, Lin Y, Quartermain D. Evaluation of the repeated open-space swim model of depression in the mouse. Pharmacol Biochem Behav 2008;91:190–5.10.1016/j.pbb.2008.07.006Suche in Google Scholar PubMed PubMed Central

[29] Seibenhener ML, Wooten MC. Use of the open field maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp 2015;96:e52434.10.3791/52434Suche in Google Scholar PubMed PubMed Central

[30] Czéh B, Fuchs E, Wiborg O, Simon M. Animal models of major depression and their clinical implications. Prog Neuro-Psychopharmacol Biol Psychiatry 2016;64:293–310.10.1016/j.pnpbp.2015.04.004Suche in Google Scholar PubMed

[31] Castagné V, Moser P, Roux S, Porsolt RD. Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr Protoc Pharmacol 2011;55:8–10.10.1002/0471142301.ns0810as55Suche in Google Scholar PubMed

[32] Slattery DA, Cryan JF. The ups and downs of modelling mood disorders in rodents. ILAR J 2014;55:297–309.10.1093/ilar/ilu026Suche in Google Scholar PubMed

[33] Cryan JF, Slattery DA. Animal models of mood disorders: recent developments. Curr Opin Psychiatry 2007;20:1–7.10.1097/YCO.0b013e3280117733Suche in Google Scholar PubMed

[34] Stone EA, Lin Y. Open‐space forced swim model of depression for mice. Curr Protoc Neurosci 2011;54:1–8.10.1002/0471142301.ns0936s54Suche in Google Scholar PubMed PubMed Central

[35] Liu B, Liu J, Wang M, Zhang Y, Li L. From serotonin to neuroplasticity: evolvement of theories for major depressive disorder. Front Cell Neurosci 2017;11:305.10.3389/fncel.2017.00305Suche in Google Scholar PubMed PubMed Central

[36] Slattery DA, Cryan JF. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc 2012;7:1009–14.10.1038/nprot.2012.044Suche in Google Scholar PubMed

[37] Bogdanova OV, Kanekar S, D’Anci KE, Renshaw PF. Factors influencing behavior in the forced swim test. Physiol Behav 2013;118:227–39.10.1016/j.physbeh.2013.05.012Suche in Google Scholar PubMed PubMed Central

[38] Amoateng P, Osei-Safo D, Kukuia KK, Adjei S, Agbemelo-Tsomafo C, Adu-Poku SN, et al. Psychotropic effects of an alcoholic extract from the leaves of Albizia zygia(Leguminosae-Mimosoideae). Evid Based Complement Altern Med 2017; 2017: 9297808.10.1155/2017/9297808Suche in Google Scholar PubMed PubMed Central

[39] Ghadage DM, Kshirsagar PR, Pai SR, Chavan JJ. Extraction efficiency, phytochemical profiles and antioxidative properties of different parts of Saptarangi (Salacia chinensis L.)–an important underutilized plant. Biochem Biophys Rep 2017;12:79–90.10.1016/j.bbrep.2017.08.012Suche in Google Scholar PubMed PubMed Central

[40] Srivasta N, Chauhan AS, Sharma B. Isolation and characterization of some phytochemicals from Indian traditional plants. Biotechnol Res Int 2012; 2012: 549850.10.1155/2012/549850Suche in Google Scholar

[41] Mulinari S. Monoamine theories of depression: historical impact on biomedical research. J Hist Neurosci 2012;21:366–92.10.1080/0964704X.2011.623917Suche in Google Scholar PubMed

[42] Nickell JR, Siripurapu KB, Vartak A, Crooks PA, Dwoskin LP. The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse. In: Dwoskin LP, editor. Advances in Pharmacology. Vol 69. San Diego: Elsevier, 2014:71–106. Available at: https://doi.org/10.1016/B978-0-12-420118-7.00002-0. Accessed: 16 Sep 2019.10.1016/B978-0-12-420118-7.00002-0Suche in Google Scholar PubMed PubMed Central

[43] Saini R, Raju M, Chaudhury S, Srivastava K. Accelerated antidepressant response to lithium augmentation of imipramine. Indian Psychiatry J 2016;25:93–100.10.4103/0972-6748.196057Suche in Google Scholar PubMed PubMed Central